Tert-butyl 5-[[[2-[3-(benzylsulfonylamino)-6-methyl-2-oxopyridin-1-yl]acetyl]amino]methyl]-4,6-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylimino]pyrimidine-1-carboxylate | 369384-16-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: Tert-butyl 5-[[[2-[3-(benzylsulfonylamino)-6-methyl-2-oxopyridin-1-yl]acetyl]amino]methyl]-4,6-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylimino]pyrimidine-1-carboxylate
• 英文别名: tert-butyl 5-[[[2-[3-(benzylsulfonylamino)-6-methyl-2-oxopyridin-1-yl]acetyl]amino]methyl]-4,6-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylimino]pyrimidine-1-carboxylate
• CAS: 369384-16-7
• 化学式: C₃₂H₄₂N₆O₈S
• 分子量: 670.787
• InChiKey: MBEMKFFOAMVWMW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  47
• 可旋转键数：
  12
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  185
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  Tert-butyl 5-[[[2-[3-(benzylsulfonylamino)-6-methyl-2-oxopyridin-1-yl]acetyl]amino]methyl]-4,6-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylimino]pyrimidine-1-carboxylate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 N-(2-Amino-4,6-dimethyl-pyrimidin-5-ylmethyl)-2-(6-methyl-2-oxo-3-phenylmethanesulfonylamino-2H-pyridin-1-yl)-acetamide
  参考文献：
  名称：

  Non-covalent thrombin inhibitors featuring p 3 -heterocycles with P 1 -monocyclic arginine surrogates

  摘要：

  Investigations on P-2-P-3-heterocyclic dipeptide surrogates directed towards identification of an orally bioavailable thrombin inhibitor led us to pursue novel classes of achiral, non-covalent P-1-arginine derivatives. The design. synthesis. and biological activity of inhibitors NC1-NC30 that feature three classes of monocyclic P-1-arginine surrogates will be disclosed: (1) (hetero)aromatic amidines, amines and hydrox amidines, (2) 2-aminopyrazines. and (3) 2-aminopyrimidines and 2-aminotetrahydropyrimidines. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00129-4
• 作为产物：
  描述：

  2-氨基-5-溴-4,6-二甲基嘧啶 在 palladium on activated charcoal 盐酸 、 4-二甲氨基吡啶 、 氢气 作用下， 以 四氢呋喃 、 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 20.0 ℃ 、344.74 kPa 条件下， 反应 53.0h， 生成 Tert-butyl 5-[[[2-[3-(benzylsulfonylamino)-6-methyl-2-oxopyridin-1-yl]acetyl]amino]methyl]-4,6-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylimino]pyrimidine-1-carboxylate
  参考文献：
  名称：

  Non-covalent thrombin inhibitors featuring p 3 -heterocycles with P 1 -monocyclic arginine surrogates

  摘要：

  Investigations on P-2-P-3-heterocyclic dipeptide surrogates directed towards identification of an orally bioavailable thrombin inhibitor led us to pursue novel classes of achiral, non-covalent P-1-arginine derivatives. The design. synthesis. and biological activity of inhibitors NC1-NC30 that feature three classes of monocyclic P-1-arginine surrogates will be disclosed: (1) (hetero)aromatic amidines, amines and hydrox amidines, (2) 2-aminopyrazines. and (3) 2-aminopyrimidines and 2-aminotetrahydropyrimidines. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00129-4

文献信息

• Non-covalent thrombin inhibitors featuring p 3 -heterocycles with P 1 -monocyclic arginine surrogates
  作者：John E Reiner、Daniel V Siev、Gian-Luca Araldi、Jingrong Jean Cui、Jonathan Z Ho、Komandla Malla Reddy、Lala Mamedova、Phong H Vu、Kuen-Shan S Lee、Nathaniel K Minami、Tony S Gibson、Susanne M Anderson、Annette E Bradbury、Thomas G Nolan、J.Edward Semple

  DOI：10.1016/s0960-894x(02)00129-4

  日期：2002.4

  Investigations on P-2-P-3-heterocyclic dipeptide surrogates directed towards identification of an orally bioavailable thrombin inhibitor led us to pursue novel classes of achiral, non-covalent P-1-arginine derivatives. The design. synthesis. and biological activity of inhibitors NC1-NC30 that feature three classes of monocyclic P-1-arginine surrogates will be disclosed: (1) (hetero)aromatic amidines, amines and hydrox amidines, (2) 2-aminopyrazines. and (3) 2-aminopyrimidines and 2-aminotetrahydropyrimidines. (C) 2002 Elsevier Science Ltd. All rights reserved.